- Home
- ANGH vs MDCX Comparison
ANGH vs MDCX Comparison
Compare ANGH & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGH
- MDCX
- Stock Information
- Founded
- ANGH 2012
- MDCX 2008
- Country
- ANGH United Arab Emirates
- MDCX Canada
- Employees
- ANGH N/A
- MDCX N/A
- Industry
- ANGH Telecommunications Equipment
- MDCX
- Sector
- ANGH Consumer Discretionary
- MDCX
- Exchange
- ANGH Nasdaq
- MDCX Nasdaq
- Market Cap
- ANGH 32.1M
- MDCX 38.3M
- IPO Year
- ANGH N/A
- MDCX N/A
- Fundamental
- Price
- ANGH $3.30
- MDCX $1.96
- Analyst Decision
- ANGH
- MDCX Strong Buy
- Analyst Count
- ANGH 0
- MDCX 2
- Target Price
- ANGH N/A
- MDCX $23.50
- AVG Volume (30 Days)
- ANGH 292.5K
- MDCX 363.0K
- Earning Date
- ANGH 08-26-2025
- MDCX 08-11-2025
- Dividend Yield
- ANGH N/A
- MDCX N/A
- EPS Growth
- ANGH N/A
- MDCX N/A
- EPS
- ANGH N/A
- MDCX N/A
- Revenue
- ANGH $78,093,405.00
- MDCX N/A
- Revenue This Year
- ANGH N/A
- MDCX N/A
- Revenue Next Year
- ANGH N/A
- MDCX N/A
- P/E Ratio
- ANGH N/A
- MDCX N/A
- Revenue Growth
- ANGH 88.72
- MDCX N/A
- 52 Week Low
- ANGH $2.53
- MDCX $1.80
- 52 Week High
- ANGH $9.46
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- ANGH 39.65
- MDCX N/A
- Support Level
- ANGH $3.19
- MDCX N/A
- Resistance Level
- ANGH $3.52
- MDCX N/A
- Average True Range (ATR)
- ANGH 0.46
- MDCX 0.00
- MACD
- ANGH -0.00
- MDCX 0.00
- Stochastic Oscillator
- ANGH 43.75
- MDCX 0.00
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.